DK0711148T3 - Dobbeltfasede multilamellære lipidblærer - Google Patents

Dobbeltfasede multilamellære lipidblærer

Info

Publication number
DK0711148T3
DK0711148T3 DK94922214T DK94922214T DK0711148T3 DK 0711148 T3 DK0711148 T3 DK 0711148T3 DK 94922214 T DK94922214 T DK 94922214T DK 94922214 T DK94922214 T DK 94922214T DK 0711148 T3 DK0711148 T3 DK 0711148T3
Authority
DK
Denmark
Prior art keywords
lipid
blisters
double
phase
multilamellar lipid
Prior art date
Application number
DK94922214T
Other languages
English (en)
Inventor
Marianna Foldvari
Original Assignee
Pharmaderm Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmaderm Lab Ltd filed Critical Pharmaderm Lab Ltd
Application granted granted Critical
Publication of DK0711148T3 publication Critical patent/DK0711148T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Fats And Perfumes (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK94922214T 1993-07-28 1994-07-28 Dobbeltfasede multilamellære lipidblærer DK0711148T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9810293A 1993-07-28 1993-07-28
PCT/CA1994/000409 WO1995003787A1 (en) 1993-07-28 1994-07-28 Biphasic multilamellar lipid vesicles

Publications (1)

Publication Number Publication Date
DK0711148T3 true DK0711148T3 (da) 2001-01-02

Family

ID=22267097

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94922214T DK0711148T3 (da) 1993-07-28 1994-07-28 Dobbeltfasede multilamellære lipidblærer

Country Status (10)

Country Link
EP (1) EP0711148B1 (da)
AT (1) ATE195866T1 (da)
AU (1) AU7343894A (da)
CA (1) CA2168260C (da)
DE (1) DE69425750T2 (da)
DK (1) DK0711148T3 (da)
ES (1) ES2152324T3 (da)
GR (1) GR3034777T3 (da)
PT (1) PT711148E (da)
WO (1) WO1995003787A1 (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100422191B1 (ko) * 1994-08-05 2004-05-20 인파머 에스. 에이. 포스페티딜콜린과착물화된프로스타글란딘e1및/또는트록세루틴을함유하는발기불능국부치료용조성물
US5718917A (en) * 1995-12-15 1998-02-17 Harvard Scientific Corporation PGE-1 containing lyophilized liposomes for use in the treatment of erectile dysfunction
GB9605915D0 (en) * 1996-03-21 1996-05-22 Univ Bruxelles Liposome encapsulated amphiphilic drug compositions
US6416740B1 (en) * 1997-05-13 2002-07-09 Bristol-Myers Squibb Medical Imaging, Inc. Acoustically active drug delivery systems
US5993852A (en) * 1997-08-29 1999-11-30 Pharmaderm Laboratories Ltd. Biphasic lipid vesicle composition for transdermal administration of an immunogen
BE1011899A6 (fr) 1998-04-30 2000-02-01 Ucb Sa Compositions pharmaceutiques gelifiables utilisables.
JP2007533647A (ja) * 2003-10-24 2007-11-22 アルザ・コーポレーシヨン 脂質粒子の調製
EP2034961A1 (de) * 2006-06-30 2009-03-18 Gertrud Langhoff Solubilisatformulierungen
EP2134353B1 (en) * 2007-03-30 2016-11-16 Helix Biopharma Corp. Biphasic lipid-vesicle composition and method for treating cervical dysplasia by intravaginal delivery
FR2939313B1 (fr) * 2008-12-10 2012-03-23 St Hubert Procede de preparation de vesicules a caractere hydrophobe comprenant une cavite interne hydrophobe.
US20120021036A1 (en) * 2009-01-15 2012-01-26 The Regents Of The University Of California Composite nanostructures and methods for making and using them
GB201202333D0 (en) * 2012-02-10 2012-03-28 Stepan Co Structured surfactant suspending systems
US9668474B2 (en) 2012-02-10 2017-06-06 Stepan Company Structured surfactant suspending systems
US8986732B2 (en) 2013-08-12 2015-03-24 Helix Biopharma Corporation Biphasic lipid-vesicle compositions and methods for treating cervical dysplasia by intravaginal delivery
US10159646B2 (en) 2013-08-12 2018-12-25 Altum-Avro Pharma Partnership Biphasic lipid-vesicle compositions and methods for treating cervical dysplasia by intravaginal delivery
KR101739208B1 (ko) 2014-12-30 2017-05-25 (주)셀트리온 표피성장인자와 리포좀의 하이브리드형 다중층 나노구조체 및 그 제조방법
LT3512495T (lt) 2016-09-15 2022-12-27 Camurus Ab Prostaciklino analogo vaisto formos
AU2018273410A1 (en) * 2017-05-26 2020-01-16 Altum Pharmaceuticals Inc. Biphasix cannabinoid delivery
BR112020025764A2 (pt) 2018-06-19 2021-05-11 Biontech Us Inc. neoantígenos e usos dos mesmos
TWI848045B (zh) * 2019-01-30 2024-07-11 德商巴地斯顏料化工廠 供個人護理應用之液晶脂質顆粒之化妝品組合物
WO2021056106A1 (en) 2019-09-23 2021-04-01 Dds Research Inc. Lipid vesicle compositions with penetration enhancing agents
MX2023011157A (es) 2021-03-24 2024-01-25 Glo Pharma Inc Peptidos y metodos para reducir la pigmentacion de la piel.
EP4426263A4 (en) * 2021-11-04 2025-09-17 Glo Pharma Inc METHODS AND COMPOSITIONS FOR COSMETIC APPLICATIONS
CN115531319B (zh) * 2022-11-25 2023-05-05 仙乐健康科技股份有限公司 一种高稳定性脂质体及其制备方法和用途
CN121868157A (zh) * 2023-12-05 2026-04-17 莱雅公司 包含蜡、酯、氨基酸表面活性剂以及双子表面活性剂或聚甘油脂肪酸酯的具有优异质地的稳定组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS607932A (ja) * 1983-06-29 1985-01-16 Dai Ichi Seiyaku Co Ltd リポソーム懸濁液およびその製法
US5160669A (en) * 1988-03-03 1992-11-03 Micro Vesicular Systems, Inc. Method of making oil filled paucilamellar lipid vesicles
IL94103A0 (en) * 1989-04-25 1991-01-31 Nattermann A & Cie Water-containing formulations with phospholipids,their preparation and application
CA2038945A1 (en) * 1989-08-01 1991-02-02 Norman D. Weiner Topical delivery of peptides/proteins entrapped in dehydration/rehydration liposomes
AU2300092A (en) * 1991-07-03 1993-02-11 Nathan E. Scott Prostaglandin e2 treatment of impotence

Also Published As

Publication number Publication date
EP0711148A1 (en) 1996-05-15
WO1995003787A1 (en) 1995-02-09
DE69425750D1 (de) 2000-10-05
GR3034777T3 (en) 2001-02-28
CA2168260C (en) 2000-04-11
AU7343894A (en) 1995-02-28
DE69425750T2 (de) 2001-04-26
ATE195866T1 (de) 2000-09-15
ES2152324T3 (es) 2001-02-01
PT711148E (pt) 2001-02-28
CA2168260A1 (en) 1995-02-09
EP0711148B1 (en) 2000-08-30

Similar Documents

Publication Publication Date Title
DK0711148T3 (da) Dobbeltfasede multilamellære lipidblærer
FI973320L (fi) Kiinteitä aktiiviainetta sisältäviä valmisteita
AU6319698A (en) Liposomes containing active agents
DK433484D0 (da) Medikamentholdigt lipidvesikelpraeparat
BR9508913A (pt) Preparação de lipossomas multivesiculares para liberação controlada de agentes ativos
DE69631970D1 (de) Archaeoliposome, koenzym q10 enthaltende archaeoliposome und koenzym q10 enthaltende liposome als adjuvans und wirkstoffabgabevehikel
FR2760193B1 (fr) Lipides et complexes de lipides cationiques et de substances actives, notamment pour la transfection de cellules
SI1051174T2 (sl) Gastroprotektirane omeprazolne mikrogranule, postopek za pridobivanje le-teh in farmacevtski pripravki
DK725888D0 (da) Overtrukne aktive stoffer
RU95101387A (ru) Концентрированный водный раствор аргатробана
PL322688A1 (en) Cages for holding pasty and liquid preparations with active substance
FI954990A0 (fi) Aktiiviainetta sisältävä transdermaalinen valmiste
FI972542L (fi) Transdermaalijärjestelmä useamman aktiivisen aineen samanaikaista antamista varten
EA199900715A1 (ru) Липидные комплексы и липосомы совершенно нерастворимых комплексов платины
DE69530368D1 (de) Vinca-alkaloid vesikel mit erhöhter wirksamkeit und tumor-zielausrichtung
ES2134846T3 (es) Formulacion de antibiotico y uso para infecciones resistentes a farmacos.
HU9601476D0 (en) Process for echancing the stability of liposomal suspensions containing hydrophilic active agents
DK0927222T3 (da) Termoplastiske polyurethaner indeholdende virksomme stoffer
ATE226843T1 (de) Mittel zur tumortherapie auf liposomenbasis, die tamoxifen enthalten
EP0198765A3 (en) Preparation of liposomes
GB2303791B (en) Method of preparing a predetermined active agent stock solution for liposomal microencapsulation of active agents for agricultural uses
ATE228575T1 (de) Wirkstoffkombinationen
HRP960254B1 (en) Combinations of active fungicidal agents
CA2224565A1 (en) Agent for combating parasites in farmed fish
DE69520231D1 (de) Liposomzubereitungen enthaltend hybrid-interferon